top of page
About Vesteck Inc.
Vesteck Inc. is a clinical stage medical device company dedicated to revolutionizing the aortic repair space through the development of an advanced endosuturing platform.
The goal of the Suture-Tight™ is to eliminate graft migration and endo-leaks that lead to complex and expensive repair procedures.
Our Mission
Our mission at Vesteck is to transform the healthcare landscape through the development of advanced medical devices that set new standards for efficacy and patient safety. We are dedicated to pioneering breakthrough technologies that empower healthcare professionals and benefit patients.
The Need
Hear Vesteck CEO Joe Rafferty tell Vesteck's story, and discuss the need for the Suture-Tight™ EndoSuturing Platform for endograft fixation.
October 2021
Vesteck opens R&D and Manufacturing facility in Carlsbad, CA
September 2022
9th Pre-Clinical Study conducted
May 2023
7th clinical case completed. Cases completed in Canada and Latvia
February 2022
First Pre-Clinical study conducted with Suture-Tight™
December 2022
15th Pre-Clinical Study Completed
February 2024
14th clinical case completed. Cases completed in Canada, Latvia and Australia.
February 2023
First in Human use of Suture-Tight™ in Latvia, EU
bottom of page